They studied 123 patients of primary and recurrent prostate cancer who were imaged by both [68Ga]Ga-PSMA and 11C-Choline PET/CT and found exclusive 11C-Choline PET/CT positive lesions to be 6% nodal and 2% skeletal lesions [24]. The gene discussed is FOLH1; the disease is prostate cancer.